🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
Go Digit invests Rs 30 Cr in Dr. Reddy’s Lab
Entrackr
·
5m ago
Medial
Go Digit invests Rs 30 Cr in Dr. Reddy’s Lab Insurtech company Go Digit has invested Rs 30 crore in pharmaceutical major Dr. Reddy’s Laboratories, acquiring a 0.32% stake in the company. “The investment in shares is being made in the ordinary course of the investment function of the company,” Go Digit said in an exchange filing. Established in 1984 by Kallam Anji Reddy, Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company that manufactures and markets affordable medicines. It provides a portfolio of products and services, including active pharmaceutical ingredients (APIs), custom pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Founded in 2017 by Kamesh Goyal, Go Digit is a full-stack digital insurance company that offers a wide range of non-life insurance policies across sectors such as motor vehicle, health, travel, and property, among others. Go Digit’s profit after tax (PAT) surged 176.46% year-on-year (YoY) to Rs 118.52 crore in Q3 FY25, driven by steady revenue expansion and a controlled rise in operating expenses. As of December 31, 2024, Go Digit’s assets under management stood at Rs 18,939 crore. Go Digit competes with other notable players like Acko, ICICI Lombard, Bajaj Allianz, Tata AIG, among others.
View Source
Related News
Go Digit’s IPO: Valuation cut by 25% to $3 bn
The Arc Web
·
1y ago
Medial
Go Digit will launch its Rs 2,615 crore ($313 million) IPO next week, valued at Rs 25,000 crore ($3 billion). The price range is Rs 258-272, a 25% discount from its previous Rs 33,800 crore valuation. This makes Go Digit the first Indian unicorn to IPO below private valuation. The offering includes Rs 1,125 crore in primary capital, reduced from Rs 1,250 crore, and 54.8 million shares in the offer for sale.
View Source
Bombay HC sets aside Rs 170 Cr GST demand against Go Digit, orders fresh adjudication
Entrackr
·
1m ago
Medial
Bombay HC sets aside Rs 170 Cr GST demand against Go Digit, orders fresh adjudication The Bombay High Court has provided major relief to Go Digit General Insurance by setting aside a Rs 170.29 crore GST demand raised by the Chennai South Commissionerate of GST & Central Excise. The order, dated July 4, includes Rs 154.8 crore in alleged tax dues and Rs 15.48 crore in penalties for the period from July 2017 to March 2022. According to Go Digit’s filing accessed from the National Stock Exchange (NSE), the High Court noted that the GST Council had already discussed this industry-wide issue and issued related circulars. Now, the court has asked the tax department to review the case again, keeping those guidelines in mind, and complete the process within three months. This update comes just a few months after Go Digit listed on the stock market. The tax demand was earlier mentioned in its Red Herring Prospectus under “Material Tax Proceedings.” The company said it is reviewing legal options and is waiting for the official court order to be delivered. Importantly, the company clarified that the case is part of a broader issue impacting the insurance industry at large and that no financial implications arise at this stage due to the High Court's intervention. The insurance company recorded a 2.2X increase in profits to Rs 116 crore during the last quarter of the previous fiscal year (Q4FY25). Meanwhile, for the full fiscal year (FY25), its profits surged 133% to Rs 425 crore. The company is currently traded at Rs 333.9 as of 11.25 AM with a total market capitalization of Rs 30,828 crore or $3.6 billion.
View Source
GIVA grabs Rs 450 Cr funding from Creaegis Investment, existing investors
YourStory
·
1m ago
Medial
Jewellery brand GIVA raised Rs 450 crore in Series C funding led by Creaegis Investment and existing backers, including Premji Invest and Epiq Capital, reaching a valuation of Rs 3,950 crore. The funds aim to boost GIVA's retail expansion and lab-grown diamond sales. Despite a 66% rise in FY24 revenue, losses increased by 30% due to higher metal procurement costs. GIVA forecasts Rs 809 crore revenue with a PBT of Rs 10 crore for FY26.
View Source
Go Zero secures Rs 30 Cr in Series A round
Entrackr
·
4m ago
Medial
Snippets Go Zero secures Rs 30 Cr in Series A round Ice cream brand Go Zero has raised Rs 30 crore (around $3.4 million) in its Series A funding round from existing investors DSG Consumer Partners, Saama Capital, and V3 Ventures Ice cream brand Go Zero has raised Rs 30 crore (around $3.4 million) in its Series A funding round from existing investors DSG Consumer Partners, Saama Capital, and V3 Ventures. Subtle participation also came from notable investors Aman Gupta (through Shark Tank India) and Namita Thapar (outside the tank). With this round, Go Zero has raised a total of $6 million to date. Earlier in June 2024, Go Zero raised $1.5 million in its follow-on pre-Series A funding round from DSG Consumer Partners, Saama, and V3 Ventures. The proceeds will be used to fuel supply chain expansion, innovation in product offerings, and brand growth as Go Zero continues its expansion on quick-commerce platforms in tier I and tier II markets. Founded by Kiran Shah, Go Zero has a diversified product portfolio featuring low-calorie, high-protein, and vegan ice creams. The startup claims that all its products are sweetened with plant-based sweeteners, which are low in calories. Since its inception in July 2022, Go Zero claims to have offer 100% sugar-free products with 50% fewer calories than traditional ice creams. The brand has achieved 5X revenue growth in its second year and 3X in the third. Despite January being the off-season for ice cream sales, Go Zero recorded its highest-ever sales in January 2025, crossing Rs 5 crore in revenue. With a strong presence across Mumbai, Delhi, Pune, Bangalore, and Hyderabad, Go Zero is also set to launch new guilt-free formats, including kulfi sticks and cassata. The firm currently operates two manufacturing units in Mumbai and Bangalore. Go Zero competes with Hangyo Ice Cream, Hocco, and NIC. In 2023, NIC raised $11 million in a funding round led by Jungle Ventures, while Hocco also secured $12 million from the Chona family and other investors. Meanwhile, Hangyo Ice Cream secured India's largest venture funding for an ice cream brand, raising $25 million from Faering Capital in August last year.
View Source
Virat Kohli-backed Go Digit debuts at 5% premium over IPO price
Economic Times
·
1y ago
Medial
Go Digit, a leading digital insurer, debuted on the NSE at a 5.15% premium. The shares opened at Rs 286 compared to the issue price of Rs 272. The company's IPO was oversubscribed nearly 10 times due to strong interest from retail and institutional buyers. The net proceeds from the IPO will be used to enhance the company's capital base and solvency levels. Go Digit has seen significant growth, with a rise in net earned premiums and a profit after tax in the 9-month period ending December 2023 compared to the previous financial year.
View Source
Exclusive: Fireside invests in lab grown jewellery brand Aukera
Entrackr
·
1y ago
Medial
Lab-grown jewellery brand Aukera has raised Rs 26.7 crore (approximately $3.2 million) in its Series A round led by Fireside Ventures. This is the first institutional investment for a year-old omnichannel brand, which mostly deals in diamonds. The board at Aukera Jewellery has passed a special resolution to issue 10 equity and 8,155 Series A CCPS at an issue price of Rs 32,713 each to raise Rs 26.7 crore, its regulatory filing sourced from the Registrar of Companies (RoC) shows. Fireside Ventures spearheaded the Series A round with Rs 23.75 crore while Sparrow Capital and Eternal Emerging Enterprises participated with Rs 1.39 crore and 1.57 crore, respectively. The company will use these funds for expansion and general corporate business, as decided by the board, the filing further added. As per TheKredible’s estimates, the company has been valued at around Rs 124 crore or $15 million post-allotment. This round appears to be an ongoing one and it may raise more capital. Following the fresh proceeds, Fireside Ventures holds a significant 19.20% stake in the company while Sparrow Capital and Eternal Enterprises will command 7.59% and 5.89% of Aukera Jewellery. With the fundraise, the company has also expanded its employee stock options pool with addition of 1,180 options. At present, its total ESOP pool consists of 1,896 options. According to TheKredible estimates, Aukera’s overall ESOP pool is worth Rs 6.20 crore. Founded in 2023, Aukera is a women-centric jewellery brand that offers lab-grown diamond jewellery in white, rose, yellow gold, and platinum. It sells its products through its website and has 2 stores in Bengaluru. The Bengaluru-based firm competes with a clutch of firms including Fiona Diamonds, Limelight Lab Grown Diamonds, and Jewelbox. Aditya Birla-backed GIVA also offers a lab-grown diamond jewellery line.
View Source
Digit IPO: Insurtech Raises INR 1,176 Cr From Anchor Investors
Inc42
·
1y ago
Medial
Insurtech company Go Digit General Insurance (Digit) has raised INR 1,176.6 Cr ($158.7m) from its anchor investors ahead of its IPO, which is set to raise a total of INR 2,614.6 Cr ($352.7m). The IPO includes a fresh issue of shares worth INR 1,125 Cr ($151.6m) and an offer for sale (OFS) of 5.47 Cr ($737k) shares. The IPO is scheduled to open on 15 May and close on 17 May, with Digit planning to list on the BSE and NSE on 23 May.
View Source
IRDA imposes Rs 1 Cr fine on Go Digit Insurance
Entrackr
·
1y ago
Medial
The Insurance Regulatory and Development Authority of India (IRDAI) has imposed a penalty of Rs 1 crore on IPO-bound Go Digit General Insurance for inordinate delay in the filing the particulars of the joint venture agreement related to the change in the conversion ratio of compulsorily convertible preference shares (CCPS) issued by its parent company to FAL Corporation. In November, the regulator had issued a show cause notice to the firm in the matter. About 63,00,000 CCPS were issued by Go Digit’s parent company—Go Digit Info Works Services Pvt. Ltd. (GDISPL)— to Fairfax Group-owned FAL Corporation. During the time of the joint venture agreement in 2017, it was agreed upon that the conversion ratio was “1 CCPS for 2.324 equity shares”, which was changed by the company to “2.324 CCPS for 1 equity share.” Instead of 63,00,000 CCPS, a total of 78,00,000 were issued by GDISPL, the regulator noted in the order date of May 2, 2024. The company’s response further admits that “the specific non-submission of JV agreement to the authority was purely inadvertent and unintentional.” Digit Insurance has been facing issues from the regulator ever since it filed its DRHP in August 2022. Initially, SEBI did not provide the approval and sought additional information while it also returned Digit’s prospectus over employee stock plans. In April 2023, the company refiled its draft IPO papers. In November, the firm received show cause notice and multiple advisories from IRDAI for non-disclosure of change in the conversion ratio of compulsorily convertible preference shares (CCPS). However, Digit managed to get SEBI’s approval to raise funds through IPO in March this year. Digit is among a bunch of companies which had also faced friction from the regulators in the past. Last month, FirstCry had to refile its draft IPO papers after SEBI’s concern. Earlier, fintech firm MobiKwik and travel tech company TBO also refiled their draft papers with reduced IPO sizes.
View Source
EaseMyTrip invests Rs 90 Cr in two overseas firms; enters medical tourism space
Entrackr
·
10m ago
Medial
Online travel aggregator (OTA) platform EaseMyTrip has acquired a 30% stake in Rollins International and a 49% stake in Pflege Home Healthcare to enter the medical tourism market. The board of directors at EaseMyTrip has approved the acquisition of Rollins International (30%) and Pflege Home Healthcare (49%) at a consideration of Rs 60 crore and Rs 30 crore, respectively, the company’s disclosure accessed from the National Stock Exchange shows. According to the filings, the consideration of Rs 90 crore will be paid to Rollins and Pflege in the form of an equity swap i.e. issuance of EaseMyTrip’s shares. “The acquisition is a strategic expansion into the rapidly growing medical tourism sector and align with EaseMyTrip’s mission to offer holistic travel solutions by integrating wellness and healthcare services into its service portfolio as medical tourism.” the company added in the disclosure. Pflege Healthcare is a UAE-based medical tourism provider which offers international patients access to treatments worldwide with partnerships across top-tier medical institutions and leading hotel chains. Rollins International is a subsidiary of Singapore-based RHA Holding which focuses on wellness, healthcare, and consumer products such as gluten and lactose-free food products, allergen-free health supplements, wellness therapies and treatments. Earlier this month, EaseMyTrip’s board also approved the proposal for the manufacturing of electric buses. Over the years, the company expanded its portfolio through the acquisition of several firms in the travel and hospitality sectors, including Guideline Travels Holidays, TripShope Travel Technologies, and Dook Travels last year. The Nishant Pitti-led firm recorded a 6.8% quarter-on-quarter decrease in its revenue to Rs 152.6 crore in the first quarter of the ongoing fiscal year as compared to Rs 164 crore in Q4 FY24. A slight decline in scale led EasyMyTrips’s profits to down by 13% to Rs 33.92 crore in the same period.
View Source
Dr. Reddy’s to buy Haleon’s nicotine replacement therapy biz outside US for $633 mn
VCCircle
·
1y ago
Medial
Indian pharmaceutical company Dr. Reddy's Laboratories has agreed to acquire British consumer healthcare company Haleon's nicotine replacement therapy business outside the US for £500 million ($633 million). The deal includes the purchase of Haleon group company Northstar Switzerland, which owns the popular Nicotinell brand of nicotine gum, lozenges, and patches. The acquisition will expand Dr. Reddy's over-the-counter product portfolio and strengthen its presence in the consumer healthcare market. The transaction is expected to close in late 2024, subject to regulatory approvals.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in